SLC5A5 and Familial prostate cancer: In order to take advantage of the therapeutic and imaging potential of hNIS, several groups have attempted exogenous NIS gene transfer in several human cancers including head and neck squamous cell cancers, non-small cell lung, thyroid, liver, colorectal, and prostate cancers, as well as glioma and multiple myeloma [22].